Evidence map›Paper›PMID 27354783›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2016

Lung perfusion and emphysema distribution affect the outcome of endobronchial valve therapy.

Christian Thomsen, Dorothea Theilig, Dominik Herzog, Alexander Poellinger, Felix Doellinger, Nils Schreiter, Vera Schreiter, Dirk Schürmann, Bettina Temmesfeld-Wollbrueck, Stefan Hippenstiel and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Simultaneous Imaging of Ventilation and Gas Exchange with HyperpolarizedAmerican journal of respiratory and critical care medicine · 2022
    Article
  10. Bronchoscopic lung volume reduction: status quo.Annals of translational medicine · 2020
    Review
  11. Article
  12. Endoscopic Lung Volume Reduction Results in Improvement of Diaphragm Mobility as Measured by Sonography.International journal of chronic obstructive pulmonary disease · 2020
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Observational
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Christian ThomsenDepartment of Internal Medicine/Infectious Diseases and Respiratory Medicine.
Dorothea TheiligInstitute of Radiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Dominik HerzogDepartment of Internal Medicine/Infectious Diseases and Respiratory Medicine.
Alexander PoellingerInstitute of Radiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Felix DoellingerInstitute of Radiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Nils SchreiterInstitute of Nuclear Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Vera SchreiterInstitute of Radiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Dirk SchürmannDepartment of Internal Medicine/Infectious Diseases and Respiratory Medicine.
Bettina Temmesfeld-WollbrueckDepartment of Internal Medicine/Infectious Diseases and Respiratory Medicine.
Stefan HippenstielDepartment of Internal Medicine/Infectious Diseases and Respiratory Medicine.
Norbert SuttorpDepartment of Internal Medicine/Infectious Diseases and Respiratory Medicine.
Ralf-Harto HubnerDepartment of Internal Medicine/Infectious Diseases and Respiratory Medicine.
Charité - Universitätsmedizin Berlin · DEResearch Institute of Radiology · BY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The exclusion of collateral ventilation (CV) and other factors affect the clinical success of endoscopic lung volume reduction (ELVR). However, despite its benefits, the outcome of ELVR remains difficult to predict. We investigated whether clinical success could be predicted by emphysema distribution assessed by computed tomography scan and baseline perfusion assessed by perfusion scintigraphy. Data from 57 patients with no CV in the target lobe (TL) were retrospectively analyzed after ELVR with valves. Pulmonary function tests (PFT), St George's Respiratory Questionnaire (SGRQ), and 6-minute walk tests (6MWT) were performed on patients at baseline. The sample was grouped into high and low levels at the median of TL perfusion, ipsilateral nontarget lobe (INL) perfusion, and heterogeneity index (HI). These groups were analyzed for association with changes in outcome parameters from baseline to 3 months follow-up. Compared to baseline, patients showed significant improvements in PFT, SGRQ, and 6MWT (all P≤0.001). TL perfusion was not associated with changes in the outcome. High INL perfusion was significantly associated with increases in 6MWT (P=0.014), and high HI was associated with increases in forced expiratory volume in 1 second (FEV1), (P=0.012). Likewise, there were significant correlations for INL perfusion and improvement of 6MWT (r=0.35, P=0.03) and for HI and improvement in FEV1 (r=0.45, P=0.001). This study reveals new attributes that associate with positive outcomes for patient selection prior to ELVR. Patients with high perfusions in INL demonstrated greater improvements in 6MWT, while patients with high HI were more likely to respond in FEV1.

Indexed as

Pulmonary CirculationAgedBronchoscopyClinical Decision-MakingFemaleForced Expiratory VolumeHumansLungMaleMiddle AgedPatient SelectionPerfusion ImagingPredictive Value of TestsProsthesis DesignPulmonary EmphysemaRecovery of FunctionCOPDemphysema distributionendoscopic lung volume reductionlung perfusionvalves

Identifiers

PMID27354783
PMCPMC4907487
OpenAlexW2417993526

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.